BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6761583)

  • 1. Molecular identification of human T-lymphocyte antigens defined by the OKT5 and OKT8 monoclonal antibodies.
    Phan-Dinh-Tuy F; Niaudet P; Bach JF
    Mol Immunol; 1982 Dec; 19(12):1649-54. PubMed ID: 6761583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens.
    Platsoucas CD; Good RA
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4500-4. PubMed ID: 6974866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical analysis of human T lymphocyte differentiation antigens T4 and T5.
    Terhorst C; van Agthoven A; Reinherz E; Schlossman S
    Science; 1980 Jul; 209(4455):520-1. PubMed ID: 6967228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.
    Reinherz EL; Kung PC; Goldstein G; Levey RH; Schlossman SF
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1588-92. PubMed ID: 6966400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further dissection of the functional heterogeneity within the OKT4+ and OKT8+ human T cell subsets.
    Thomas Y; Rogozinski L; Rothman P; Rabbani LE; Andrews S; Irigoyen OH; Chess L
    J Clin Immunol; 1982 Jul; 2(3 Suppl):8S-14S. PubMed ID: 6215426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four distinct antigen systems on human thymus and T cells defined by monoclonal antibodies: immunohistological and immunochemical studies.
    Ishii Y; Kon S; Takei T; Fujimoto J; Kikuchi K
    Clin Exp Immunol; 1983 Jul; 53(1):31-40. PubMed ID: 6347477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of target antigens of monoclonal reagents OKT5, OKT8, and Leu2A, which inhibit effector function of human cytotoxic T lymphocytes.
    Snow P; Spits H; De Vries J; Terhorst C
    Hybridoma; 1983; 2(2):187-99. PubMed ID: 6205976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population.
    Thomas Y; Rogozinski L; Rabbani L; Chess A; Goldstein G; Chess L
    J Mol Cell Immunol; 1984; 1(2):103-13. PubMed ID: 6152892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human autologous rosette-forming cells. I. Expression of cell surface antigens in relation to age and lymphoid organ distribution.
    Nalet V; Fournier C
    Cell Immunol; 1983 Dec; 82(2):403-14. PubMed ID: 6606493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell subsets in human lymphocytes maintained in IL-2 medium after PHA or mixed lymphocyte reaction activation.
    Kurnick JT; Warrens AR; Moscicki RA; Leary CP
    Clin Immunol Immunopathol; 1983 Jun; 27(3):444-51. PubMed ID: 6223760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of human T cell subsets defined by monoclonal antibodies. II. Collaborative T-T interactions in the generation of TNP-altered-self-reactive cytotoxic T lymphocytes.
    Friedman SM; Hunter SB; Irigoyen OH; Kung PC; Goldstein G; Chess L
    J Immunol; 1981 May; 126(5):1702-5. PubMed ID: 6971312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease activity markers in multiple sclerosis. Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8.
    Rice GP; Finney D; Braheny SL; Knobler RL; Sipe JC; Oldstone MB
    J Neuroimmunol; 1984 Apr; 6(2):75-84. PubMed ID: 6233298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface phenotype and in vitro function of adult T-cell leukemia cells.
    Uchiyama T; Hattori T; Wano Y; Tsudo M; Takatsuki K; Uchino H
    Diagn Immunol; 1983; 1(3):150-4. PubMed ID: 6094084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological modification of immunoregulatory T lymphocytes . II. Modulation of T lymphocyte cell surface characteristics.
    Birch RE; Rosenthal AK; Polmar SH
    Clin Exp Immunol; 1982 Apr; 48(1):231-8. PubMed ID: 6177462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8.
    Perussia B; Fanning V; Trinchieri G
    J Immunol; 1983 Jul; 131(1):223-31. PubMed ID: 6408172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of T lymphocyte subsets in human colostrum.
    Richie ER; Bass R; Meistrich ML; Dennison DK
    J Immunol; 1982 Sep; 129(3):1116-9. PubMed ID: 6980919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of T-lymphocyte differentiation antigens: potential relevance for multiple sclerosis.
    Antel J; Oger JJ; Jackevicius S; Kuo HH; Arnason BG
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3330-4. PubMed ID: 6212930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Orthoclone monoclonal antibodies in the study of selected dermatologic conditions.
    Berger CL; Kung P; Goldstein G; DePietro W; Takezaki S; Chu A; Fithian E; Edelson RL
    Int J Immunopharmacol; 1981; 3(3):275-82. PubMed ID: 6974710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody analysis of T-lymphocyte subsets in young and aged adults.
    Nagel JE; Chrest FJ; Pyle RS; Adler WH
    Immunol Commun; 1983; 12(2):223-237. PubMed ID: 6603416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.